The aim of the Cancer area is to improve the outcome and quality of life of cancer patients. Cancer area directs its efforts to unveil and understand the mechanisms of the cancer origin and progression. The ultimate goal is to translate this knowledge into new diagnostic, prognostic and therapeutic solutions. Our bench to bed comprehensive research includes the generation of relevant disease models, biomarker studies, drug development and clinical trials.
RESEARCH GROUPS
Hepato-bilio-pancreatic surgery (HBP) and liver transplantation
236
Number of publications
53.81
%
% Q1
25
%
% D1
68.22
%
% Leadership
55.28
%
% Female Leadership
2.00
CROWN (2021-2025)
14.94
%
HCP10% (2021-2025)
69.92
%
% Open access
30.51
%
% International Collaboration
34
Highly cited papers / HCP 1% (2021-2025)
14
Publications in high-IF journals with high Altmetric scores
112
%
Number of Ongoing Projectes (total)
18
International ongoing projects
15
Number of New projects (total)
1
International new projects
7
Number Active clinical Trials
1
Number New Clinical Trials
18
Number of Theses
CORE/MISSIONS
Innovative & Advanced Therapies
Transplant & Immunomodulation
TEAM
Group Leader
Concepción Gómez Gavara
Principal Investigator (PI)
Concepción Gómez Gavara, Elizabeth Pando Rau, Jesús Quintero Bernabeu.
Researchers
Itxarone Bilbao Aguirre, Cristina Dopazo Taboada, Mireia Caralt Barba, Piero Alberti Delgado, Laia Blanco Cuso, Maria Mercada Hally, Cristina Padrós Fornieles, José Andrés Molino Gahete
PhD Students
Sotiris Papadiamantis, Laura Vidal Piñeiro, Mar Dalmau Romero, Martín Huerta García, Rodrigo Mata Mata, Nair Fernandes Montes, Sara Villasante Mateos, Pablo Lopez Lusa, Kevin Diaz Alvarez, Claudia Cabau Talern, Cristina Miñarro Cervera, Isabel García Barba
Lab Technicians
Esther Delgado Pascual, Raquel Massip Arribas, Nikita Bilbao Aguirre, Nicolau Farre Saurí
Nursing and Technical Staff
María Adela Amat Huerta, Sergi Capilla Tomás, Julián Serrano Carmona, Teresa Eixarch Lanaspa, Lis Vidal Valdivia
SELECTED PUBLICATIONS
Villasante S, Fernandes N, Perez M, Cordobés MA, Piella G, Martinez M, Gomez-Gavara C, Blanco L, Alberti P, Charco R, Pando E.
Pancreatia Study Collaborators. Prediction of Severe Acute Pancreatitis at a Very Early Stage of the Disease Using Artificial Intelligence Techniques, Without Laboratory Data or Imaging Tests: The PANCREATIA Study.
Ann Surg . 2024 Nov 5.
DOI: 10.1097/SLA.0000000000006579
IF: 7.9
Villasante S, Fernandes N, Perez M, Cordobés MA, Piella G, Martinez M, Gomez-Gavara C, Blanco L, Alberti P, Charco R, Pando E.
Pancreatia Study Collaborators. Prediction of Severe Acute Pancreatitis at a Very Early Stage of the Disease Using Artificial Intelligence Techniques, Without Laboratory Data or Imaging Tests: The PANCREATIA Study.
Ann Surg . 2024 Nov 5.
DOI: 10.1097/SLA.0000000000006579
IF: 7.9
Villasante S, Fernandes N, Perez M, Cordobés MA, Piella G, Martinez M, Gomez-Gavara C, Blanco L, Alberti P, Charco R, Pando E.
Pancreatia Study Collaborators. Prediction of Severe Acute Pancreatitis at a Very Early Stage of the Disease Using Artificial Intelligence Techniques, Without Laboratory Data or Imaging Tests: The PANCREATIA Study.
Ann Surg . 2024 Nov 5.
DOI: 10.1097/SLA.0000000000006579
IF: 7.9
Villasante S, Fernandes N, Perez M, Cordobés MA, Piella G, Martinez M, Gomez-Gavara C, Blanco L, Alberti P, Charco R, Pando E.
Pancreatia Study Collaborators. Prediction of Severe Acute Pancreatitis at a Very Early Stage of the Disease Using Artificial Intelligence Techniques, Without Laboratory Data or Imaging Tests: The PANCREATIA Study.
Ann Surg . 2024 Nov 5.
DOI: 10.1097/SLA.0000000000006579
IF: 7.9
Villasante S, Fernandes N, Perez M, Cordobés MA, Piella G, Martinez M, Gomez-Gavara C, Blanco L, Alberti P, Charco R, Pando E.
Pancreatia Study Collaborators. Prediction of Severe Acute Pancreatitis at a Very Early Stage of the Disease Using Artificial Intelligence Techniques, Without Laboratory Data or Imaging Tests: The PANCREATIA Study.
Ann Surg . 2024 Nov 5.
DOI: 10.1097/SLA.0000000000006579
IF: 7.9
SELECTED PROJECTS
Preoperative Indocyanine Green administration increases intraoperative detection of Liver Tumors in Imaging-guided surgery. Study protocol for a phase IV clinical trial. The LIVERGREEN.
Principal Investigator: Concepción Gómez Gavara
Agency: Stryker
Funding: 200,000 €
Period: 2024-2027
Preoperative Indocyanine Green administration increases intraoperative detection of Liver Tumors in Imaging-guided surgery. Study protocol for a phase IV clinical trial. The LIVERGREEN.
Principal Investigator: Concepción Gómez Gavara
Agency: Stryker
Funding: 200,000 €
Period: 2024-2027
Preoperative Indocyanine Green administration increases intraoperative detection of Liver Tumors in Imaging-guided surgery. Study protocol for a phase IV clinical trial. The LIVERGREEN.
Principal Investigator: Concepción Gómez Gavara
Agency: Stryker
Funding: 200,000 €
Period: 2024-2027
Preoperative Indocyanine Green administration increases intraoperative detection of Liver Tumors in Imaging-guided surgery. Study protocol for a phase IV clinical trial. The LIVERGREEN.
Principal Investigator: Concepción Gómez Gavara
Agency: Stryker
Funding: 200,000 €
Period: 2024-2027
Preoperative Indocyanine Green administration increases intraoperative detection of Liver Tumors in Imaging-guided surgery. Study protocol for a phase IV clinical trial. The LIVERGREEN.
Principal Investigator: Concepción Gómez Gavara
Agency: Stryker
Funding: 200,000 €
Period: 2024-2027
PATENTS
Intellectual property of LiverColor Project
Priority Number: SAFECreative 2020 code 2002043013250
Priority Date: 2020
Applicants: Concepción Gómez Gavara, Itxarone Bilbao, Gemma Piella, Javier Vázquez Corral
DISSEMINATION ACTIVITIES
Split cours (Dr. Dopazo)
Place: Vall d´Hebron University Hospital
Date: 03/03/2024
Brief: Theoretical aspects and hands-on workshop in split liver transplantation.
Split cours (Dr. Dopazo)
Place: Vall d´Hebron University Hospital
Date: 03/03/2024
Brief: Theoretical aspects and hands-on workshop in split liver transplantation.
